FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Trifluoperazine Hydrochloride Tablets
Status: Currently in Shortage
»Date first posted: 10/02/2018
»Therapeutic Categories: Psychiatry

Expand all

Mylan Pharmaceuticals Inc. (Revised 12/07/2018)

Company Contact Information:
800-796-9526

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 mg (NDC 0378-2401-01) Unavailable; Estimated re-supply: February 2019 Other
2 mg (NDC 0378-2402-01) Unavaiilable; Estimated re-supply: January 2019. Other
5 mg (NDC 0378-2405-01) Unavaiilable; Estimated re-supply: January 2019. Other
10 mg (NDC 0378-2410-01) Unavaiilable; Estimated re-supply: December 2018 Other

Sandoz (Reverified 11/06/2018)

Company Contact Information:
800-525-8747

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 mg 100 count bottle (NDC 0781-8028-01) Not Available; Target supply availability TBD Other
1 mg 100 count bottle (NDC 0832-0494-11) Not Available; Target supply availability TBD Other
2 mg 100 count bottle (NDC 0781-8032-01) Not Available; Target supply availability TBD Other
2 mg 100 count bottle (NDC 0832-0495-11) Not Available; Target supply availability TBD Other
5 mg 100 count bottle (NDC 0781-8034-01) Not Available; Target supply availability TBD Other
5 mg 100 count bottle (NDC 0832-0496-11) Not Available; Target supply availability TBD Other
10 mg 100 count bottle (NDC 0781-8036-01) Not Available; Target supply availability TBD Other
10 mg 100 count bottle (NDC 0832-0497-11) Not Available; Target supply availability TBD Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English